BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31186262)

  • 1. Incidence of Ductal Carcinoma
    Ryser MD; Hendrix LH; Worni M; Liu Y; Hyslop T; Hwang ES
    Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1316-1323. PubMed ID: 31186262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-Five Year Trends in the Incidence of Ductal Carcinoma in Situ in US Women.
    Oseni TO; Zhang B; Coopey SB; Gadd MA; Hughes KS; Chang DC
    J Am Coll Surg; 2019 Jun; 228(6):932-939. PubMed ID: 30772444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
    Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a Diagnosis of Ductal Carcinoma In Situ With Death From Breast Cancer.
    Giannakeas V; Sopik V; Narod SA
    JAMA Netw Open; 2020 Sep; 3(9):e2017124. PubMed ID: 32936299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent trends and racial/ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in California women.
    Innos K; Horn-Ross PL
    Cancer; 2003 Feb; 97(4):1099-106. PubMed ID: 12569612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.
    Román M; Rué M; Sala M; Ascunce N; Baré M; Baroja A; De la Vega M; Galcerán J; Natal C; Salas D; Sánchez-Jacob M; Zubizarreta R; Castells X;
    PLoS One; 2013; 8(12):e83121. PubMed ID: 24376649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent trends in breast cancer among younger women in the United States.
    Brinton LA; Sherman ME; Carreon JD; Anderson WF
    J Natl Cancer Inst; 2008 Nov; 100(22):1643-8. PubMed ID: 19001605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
    Liu Y; West R; Weber JD; Colditz GA
    Cancer; 2019 Sep; 125(18):3225-3233. PubMed ID: 31120565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the natural history of ductal carcinoma in situ based on population data.
    Chootipongchaivat S; van Ravesteyn NT; Li X; Huang H; Weedon-Fekjær H; Ryser MD; Weaver DL; Burnside ES; Heckman-Stoddard BM; de Koning HJ; Lee SJ
    Breast Cancer Res; 2020 May; 22(1):53. PubMed ID: 32460821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium.
    Allison KH; Abraham LA; Weaver DL; Tosteson AN; Nelson HD; Onega T; Geller BM; Kerlikowske K; Carney PA; Ichikawa LE; Buist DS; Elmore JG
    Cancer; 2015 May; 121(9):1369-78. PubMed ID: 25603785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
    Virnig BA; Tuttle TM; Shamliyan T; Kane RL
    J Natl Cancer Inst; 2010 Feb; 102(3):170-8. PubMed ID: 20071685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
    Li CI; Daling JR; Malone KE
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1008-11. PubMed ID: 15824180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of ductal carcinoma in situ.
    Kerlikowske K
    J Natl Cancer Inst Monogr; 2010; 2010(41):139-41. PubMed ID: 20956818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast.
    Innos K; Horn-Ross PL
    Breast Cancer Res Treat; 2008 Oct; 111(3):531-40. PubMed ID: 17978879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid increase in incidence of breast ductal carcinoma in situ in Girona, Spain 1983-2007.
    Puig-Vives M; Pollan M; Rue M; Osca-Gelis G; Saez M; Izquierdo A; Marcos-Gragera R
    Breast; 2012 Oct; 21(5):646-51. PubMed ID: 22340960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.
    Punglia RS; Cronin AM; Uno H; Stout NK; Ozanne EM; Greenberg CC; Frank ES; Schrag D
    JAMA Oncol; 2017 Jan; 3(1):101-104. PubMed ID: 27442038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
    Narod SA; Iqbal J; Giannakeas V; Sopik V; Sun P
    JAMA Oncol; 2015 Oct; 1(7):888-96. PubMed ID: 26291673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast.
    Berkman A; F Cole B; Ades PA; Dickey S; Higgins ST; Trentham-Dietz A; Sprague BL; Lakoski SG
    Breast Cancer Res Treat; 2014 Nov; 148(2):407-13. PubMed ID: 25326349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of ductal carcinoma in situ in women undergoing screening mammography.
    Ernster VL; Ballard-Barbash R; Barlow WE; Zheng Y; Weaver DL; Cutter G; Yankaskas BC; Rosenberg R; Carney PA; Kerlikowske K; Taplin SH; Urban N; Geller BM
    J Natl Cancer Inst; 2002 Oct; 94(20):1546-54. PubMed ID: 12381707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.